Along the Road to 50 States, Steve Burden, founder and CEO of FACible Biodiagnostics, talks to Nigel about precision diagnostics and how precison medicine as a whole is the next big thing in pharma.
FACible Biodiagnostics
Along the Road to 50 States, Steve Burden, founder and CEO of FACible Biodiagnostics, talks to Nigel about precision diagnostics and how precison medicine as a whole is the next big thing in pharma.
